Trials / Completed
CompletedNCT06224803
Evaluation of Effects of Dibifree® on Regulation of Blood Sugar and HbA1c in Patients With Type II Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Global Preventive Medicine Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
At present, diabetic patients mainly use drugs to control blood sugar. However, drugs have side effects and the control effect varies among individuals. Even if diabetic patients can control their blood sugar well, long-term medication will still cause a series of complications, including retinopathy, nephropathy, diabetic foot, heart disease, etc. Vascular disease issues, etc. This study will focus on the changes in HbA1c and blood sugar in patients with confirmed diabetes after taking "Dibifree®" food supplement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Compound plant extracts | Total supplement including bitter melon (Momordica charantia) fruit extract, celery (Apium graveolens) seed extract, baker's yeast (Saccharomyces cerevisiae) cell wall extract, acerola (Malpighia emarginata) fruit extract, grape (Vitis vinifera) seed extract, green tea leaf extract, and hydrolyzed soy protein powder. |
| DIETARY_SUPPLEMENT | Indigestible dextrin | Indigestible dextrin as placebo intervention |
Timeline
- Start date
- 2020-08-26
- Primary completion
- 2021-07-21
- Completion
- 2022-01-18
- First posted
- 2024-01-25
- Last updated
- 2025-07-16
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06224803. Inclusion in this directory is not an endorsement.